Tag: common

Posted on

Common corticosteroid drug may aid weight loss

Common corticosteroid drug may aid weight loss

white pills spilled over a dark blue background, one pill has a green scribble on itShare on Pinterest
New exploration in mice implies prednisone, a widespread corticosteroid drug, may possibly assist body weight reduction. Sean Locke/Stocksy
  • Many men and women with conditions that include serious inflammation choose a everyday dose of a corticosteroid drug identified as prednisone.
  • The drug is extremely helpful but can induce weight get, muscle mass squandering, and other significant side effects.
  • A new analyze in mice has observed that a weekly dose of the exact drug could have the reverse influence, creating muscle toughness and endorsing fat decline.
  • A great deal study stays to be completed, but the scientists speculate that weekly prednisone could reduce aspect effects and reduce or take care of obesity.

Prednisone is a corticosteroid drug that decreases inflammation in a vast array of situations, like muscular dystrophy, bronchial asthma, colitis, arthritis, and psoriasis.

Having said that, whilst the treatment is really powerful, day by day prednisone can induce bodyweight attain and muscle losing, amid other serious side consequences.

Scientists are keen to find out regardless of whether a weekly dose of prednisone could give the identical anti-inflammatory benefits as a day-to-day dose, but with out advertising and marketing body weight acquire and losing.

In a not too long ago printed pilot analyze, scientists at Northwestern University Feinberg School of Medicine in Chicago, IL, identified that a as soon as-weekly dose of prednisone enhanced muscle mass efficiency in people with muscular dystrophy.

Compared with a everyday dose, the weekly procedure did not appear to bring about the common facet outcomes of corticosteroid treatment method, these types of as weight achieve, large blood sugar, and superior blood pressure.

There had been also no really serious adverse events or persistent facet results from the cure.

Regardless of whether the identical method could avert pounds attain and muscle mass losing in people who do not have muscular dystrophy is unclear, however.

To start out to solution that query, a person of the researchers has now in contrast each day and weekly prednisone in mice fed a large fat diet plan. Elizabeth M. McNallly, Professor of Medication (Cardiology) and Biochemistry and Molecular Genetics from Northwestern College Feinberg Faculty of Medication in Chicago, IL, led the review.

They located that a weekly dose prevented obesity and improved muscle mass metabolism in the animals.

By contrast, a daily dose of the drug led to pounds attain, exercising intolerance, and large blood sugar concentrations.

In addition, mice that were being presently overweight missing excess weight, obtained energy and improved their lean system mass on a weekly dose of prednisone — despite eating a high-fats diet regime.

The study has been revealed in the Journal of Experimental Medication.

“What is fascinating to me about this work is the acquiring that a straightforward improve in the dosing frequency can rework [corticosteroid drugs] from inducers to preventers of being overweight.”

– Mattia Quattrocelli, Ph.D., corresponding creator

Dr. Quattrocelli, who initiated the research even though at Northwestern, is now assistant professor at Cincinnati Children’s Healthcare facility Health-related Center and the pediatrics section at the College of Cincinnati.

The study adds to proof that a healthful, well balanced metabolism largely is dependent on the molecular “conversation” in between unwanted fat (adipose) tissue and muscles.

The researchers uncovered that in obese mice, a the moment-weekly dose of prednisone greater the volume of a signaling molecule that adipose tissue produces.

The molecule — a hormone referred to as adiponectin that is derived from fats — improved the physical exercise tolerance and energy expenditure of the animals’ muscles.

Conversely, mice that had been genetically engineered to absence adiponectin failed to respond to the once-weekly cure with prednisone.

Dr. Quattrocelli advised Medical Information Currently that researchers will will need to discover more about the mechanisms guiding the discovery before they can translate the conclusions into therapies.

“We very first have to have to collect more mechanisms in mice and potentially other animal styles in get to figure out the degree of translatability,” he explained.

“There’s really a little bit of distinction amongst obesity in mice and being overweight in human beings, and in common involving metabolic pressure in mice and metabolic anxiety in people,” he emphasized.

He additional that muscle mass in mice has a different composition to that in people, with a bigger proportion of “fast twitch” fibers.

“On top of that I want to deliver to the fore the worth of the complexity of social behavior in human beings in comparison to mice,” he mentioned.

“As human beings we have extremely, quite advanced social behaviors that directly affect when and how we try to eat and the dynamics of overall body mass in standard,” he additional.

By distinction, researchers can tightly regulate the availability of food items and other environmental things in the cages of lab mice.

“This examine provides up a really exclusive and interesting concept that has yet to be explored further more,” claimed Dr. Revital Gorodeski Baskin, an endocrinology and diabetic issues professional, and director of obesity at University Hospitals in Cleveland, OH.

“I am enthusiastic to see that just after just one significant dose of prednisone, these mice showed enhancement in physique mass, muscle mass fat burning capacity, and electrical power expenditure,” she instructed MNT.

“This might seem like a feasible treatment method tactic for obesity, with a few concerns,” Dr. Baskin additional.

She pointed out that a solitary, large dose of a steroid can result in psychological distress, poor snooze, paranoid thoughts, and stress in some men and women.

She explained substantial doses of steroids are regarded to minimize bone density and increase an infection rates, so scientists would need to examine no matter if shorter bursts of the prescription drugs could, around time, result in the similar concerns.

The scientific gains could also wane in excess of time as patients’ bodies accommodate to the therapy.

“I do, nevertheless, think that this is a very distinctive thought to advancement in energy metabolism and entire body mass,” Dr. Baskin additional. She said she looked ahead to observing further analysis into the idea.

Posted on

Common anti-nausea drugs linked to stroke risk in new study

Common anti-nausea drugs linked to stroke risk in new study

senior playing tennis seen from the backShare on Pinterest
A new study of participants aged 71.9 years, on average, found a link between the use of anti-nausea medication and increased stroke risk. Gary John Norman/Getty Images
  • A recent study found that certain anti-nausea and vomiting medications tripled the risk for ischemic stroke.
  • The risk was highest for metopimazine, followed by metoclopramide, and then domperidone.
  • More studies are needed to confirm the findings.

Providers may use antipsychotic medications to treat conditions such as schizophrenia, psychotic depression, bipolar disorder, and dementia, which cause symptoms of psychosis or losing touch with reality. Excess dopamine may play a role in psychosis.

Dopamine is a chemical messenger or neurotransmitter that influences mood, feelings of reward, and movement. Antipsychotics work by blocking dopamine receptors in the brain, which causes a decrease in dopamine levels.

There is an association between antipsychotic use and dementia in older adults and an increased risk for ischemic stroke or a blood clot blocking blood flow in the brain. Data from these studies led the United States Food and Drug Administration (FDA) to issue a black box warning to warn older people with dementia of the increased risk of death with antipsychotic use.

Other medications to treat nausea and vomiting associated with chemotherapy or migraine also block dopamine receptors or antidopaminergic antiemetics (ADA). ADAs block dopamine transmission to the intestines and the chemoreceptor trigger zone in the brain, responsible for relaying signals causing vomiting.

This led French-based researchers from Bordeaux University INSERM, Sorbonne Université, INSERM, and CHU de Bordeaux to evaluate if ADA use increases the risk of ischemic stroke.

They published their findings in The BMJ.

Researchers examined data from 2,612 adults from the French reimbursement healthcare system database between 2012 and 2016. Participants included in the study experienced an initial ischemic stroke and received reimbursement for one or more ADA(s) within 70 days before the stroke.

The researchers used reimbursements — to reflect the payment received for the treatment — as a measure of treatments administered.

The study identified 3 ADAs: domperidone, metoclopramide, and metopimazine. Domperidone and metopimazine are not approved for use to treat nausea and vomiting in the United States by the FDA.

Researchers assessed the frequency of ADA for reimbursement for each participant on days 1–14 before stroke (risk period) and days 29–42, 43–56, and 57 to 70 before stroke (reference periods).

Researchers compared participant data to a control group of 21,859 randomly selected participants who did not experience an ischemic stroke. The study matched control group participants to participants with strokes by age, sex, and ischemic stroke risk factors.

The average age of participants included in the study was 71.9 years old, and approximately one-third were men. About 97{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of those who had an ischemic stroke received one ADA medication.

The study found that participants receiving ADAs overall had a 3.12 times greater risk for ischemic stroke than the control group after adjusting for medications that may affect ischemic stroke risk.

Metopimazine significantly increased ischemic stroke risk 3.62 times, metoclopramide 3.53 times, and domperidone 2.51 times.

Metopimazine and metoclopramide cross the blood-brain barrier, which controls the movement of substances from the blood to the brain. However, domperidone does not.

Sensitivity analyses indicate that ischemic stroke risk is highest 7 days before the ischemic stroke. Sensitivity analysis is a method to determine the strength of effects seen in a study which lends credibility to the findings.

Dr. Anne Bénard-Laribière, PharmD, MSc at the University of Bordeaux Population Health and study co-author, spoke to Medical News Today.

“The publication raises a strong signal associating the use of antiemetics to an increased risk of ischemic stroke,” she said. “Right now, as this is the first study evidencing such risk, replication will be needed to confirm and strengthen the already robust findings, and ideally provide complementary information on mechanisms and risk factors.”

Dr. Walavan Sivakumar, M.D., board certified neurosurgeon and director of neurovascular surgery at Pacific Neuroscience Institute at Providence Saint John’s Health Center in Santa Monica, CA, commented to MNT, “[T]his was a well-done study […] using a consistent database that afforded very reliable data [removing] different sources of bias.”

Dr. Bénard-Laribière added, “The design we used allows self-controlling for most of [the] confounding — as the [participant] is [their] own control, so the results cannot be affected by any differences across compared [participants] in terms of genetics, for instance. The price to pay for this control with this design is the lack of possibility to provide absolute risks.”

The study did not examine other ADAs marketed in the U.S., such as prochlorperazine, promethazine, and chlorpromazine.

“Making inferences based on these results related to the specific drugs is going to be very challenging. […] There are other [ADAs] that are used that still may be okay and need to be specifically studied before making any clear recommendations.”

– Dr. Sivakumar

Dr. Sivakumar also stated that these results only apply to risk for ischemic strokes and not hemorrhagic ones, which involve bleeding in the brain.

Dr. Bénard-Laribière commented, “ADAs [use has] known risks of serious adverse effects (ventricular arrhythmia), frequent adverse effects (dyskinesia, other extrapyramidal disorders) to which this study adds a strong signal for the risk of ischemic stroke.”

She added that the benefits of the ADAs might outweigh the risks to prevent serious nausea/vomiting complications. Still, the symptomatic treatment of mild nausea may warrant other therapy.

Dr. Bénard-Laribière stated, “As for all drugs, use only when medically needed is one of the best first mitigation [measures] for known risks and potential ones.”

Posted on

Live news from January 17: Moderna chief says combined flu and Covid vaccine available in 2023, Yemen’s Houthi rebels strike UAE, China’s Xi defends ‘common prosperity’ reforms

China’s president Xi Jinping speaking via video link at the World Economic Forum’s annual meeting
China’s president Xi Jinping talking via video clip url at the World Economic Forum’s yearly conference © AFP by using Getty Visuals

China’s “common prosperity” generate is not a pursuit of egalitarianism, President Xi Jinping said in a exceptional intercontinental defence of the plan that previous calendar year rattled marketplaces from Hong Kong to New York.

Xi, whom quite a few understand as China’s most strong leader because Mao, was talking through video clip website link at the World Financial Forum’s yearly assembly — held on line this calendar year, rather than at the Swiss alpine resort Davos.

“The prevalent prosperity we motivation is not egalitarianism,” Xi reported. “We will first make the pie bigger and then divide it adequately by reasonable institutional preparations. As a climbing tide lifts all boats, all people will get a honest share from advancement and advancement gains will profit all our folks in a much more sizeable and equitable way.”

Under the coverage, spearheaded by Xi, the Chinese Communist social gathering has been reshaping the country’s enterprise and cultural landscape by using a months-very long collection of crackdowns. This has focused industries which include fintech, schooling and leisure as effectively as perceived societal ills such as celeb culture, gaming and effeminate vogue tendencies.

The moves, which have wiped billions of dollars from Chinese and international investors, have sparked worldwide debate over the political and financial motives of the coverage, and created the foreseeable future of investing in China uncertain.

Xi attempted to simplicity some issues, insisting to the Davos audience that China remained dedicated to open to overseas enterprise.

“All kinds of funds are welcome to run in China, in compliance with legal guidelines and rules and engage in a constructive purpose for the progress of a state.”

The speech arrives as China faces criticism for the erosion of democratic freedoms in Hong Kong and the treatment method of Uyghurs in Xinjiang as properly as expansive navy posturing. In response, Beijing consistently rebukes the US and its allies and associates for interfering in China’s domestic passions.

The Chinese president warned of “serious negative spillovers” if “major economies slam on the brakes or just take a U-convert in monetary policies” as the globe grapples with accelerating inflation.

Issues with industrial supply chains, tight vitality materials and soaring commodity charges posed problems, he cautioned. “These dangers compound a person a further and heighten the uncertainty about economic recovery,” he explained.

Posted on

Could common cold viruses protect against COVID-19?

Share on Pinterest
Commuters at London King’s Cross railway station on Monday, July 19, 2021. Jason Alden/Bloomberg via Getty Images
  • Other strains of human coronaviruses, such as those that cause the common cold, circulated through the human population before the emergence of SARS-CoV-2, which is responsible for COVID-19.
  • Understanding the immune response to coronaviruses that existed before the pandemic and the current SARS-CoV-2 virus may be a gateway to better understanding protective immunity to COVID-19.
  • A recent study asks whether exposure to pre-pandemic coronaviruses might protect against COVID-19.

Scientists at the University of Zurich (UZH) in Switzerland recently performed an analysis demonstrating a higher level of immunity against COVID-19 in people who had been exposed to coronaviruses circulating before the pandemic.

Prof. Alexandra Trkola, lead researcher and head of the Institute of Medical Virology at UZH, and her colleagues reported their findings in Nature Communications.

The study monitored antibody response to SARS-CoV-2 to uncover correlations with vaccine protection, disease severity, and susceptibility to infection.

The researchers also compared immune responses against SARS-CoV-2 with those against pre-pandemic coronaviruses, known as HCoVs. The four types of HCoVs that cause the common cold collectively account for around 10–15{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of adult infections and 2–6{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of all hospital admissions for lower respiratory tract infections.

“Our study shows that a strong antibody response to human coronaviruses increases the level of antibodies against SARS-CoV-2. So someone who has gained immunity to harmless coronaviruses is therefore also better protected against severe SARS-CoV-2 infections,” says Prof. Trkola.

When an immune response against one coronavirus creates immune protection against a different virus, health experts call it cross-reactivity.

The researchers analyzed serum samples from 825 participants taken before the pandemic, and assessed their immune responses to four of these HCoVs.

They also analyzed 389 serum samples from individuals who tested positive for SARS-CoV-2.

The scientists found that the people who contracted SARS-CoV-2 had lower levels of antibodies against HCoVs than the individuals who did not contract SARS-CoV-2.

Also, the people with higher levels of antibodies against HCoVs who did contract SARS-CoV-2 were less likely to need hospital treatment.

Rachel Roper, Ph.D., a professor of microbiology and immunology at East Carolina University in Greenville, NC, told Medical News Today:

“I suspected that preexisting immunity to other human coronaviruses that cause colds would affect responses to SARS-CoV-2, but we didn’t have the data until now. These researchers show convincing evidence that preexisting immunity to other human coronaviruses gives some protection against infection with SARS-CoV-2, as well as [the] development of severe disease.”

“These data partly explain why some individuals have very mild or asymptomatic infections, while others develop severe disease,” she continued.

Dr. Roper went on to say, “In addition, the data show that having an immune response to other coronaviruses helps increase the immune response to COVID-19 vaccines.”

Beyond the antibody response, she explained how “these data also suggest that T lymphocytes may respond similarly and provide some level [of] cross-protection.”

“Of course, immune responses targeting SARS-CoV-2 that are mounted by the memory cells are far more effective than cross-reactive responses. But even though the protection isn’t absolute, cross-reactive immune responses shorten the infection and reduce its severity. And this is exactly what is also achieved through vaccination, just much, much more efficiently,” says Dr. Trkola.

B lymphocytes — a type of white blood cell — produce antibodies. They form memory cells that remember the pathogen for faster antibody production in future infections.

People’s immunity to SARS-CoV-2 is most robust soon after recovering from an infection or receiving a vaccination. This immunity occurs when antibody levels against the virus are still high. As these levels begin to drop, protection against the virus diminishes.

At this point, the process known as immunological memory can quickly reactivate the body’s production of antibodies and T cells and confer renewed immunity against the circulating viruses.

Dr. Roper went on to say, “These data give us a reason to be grateful for catching the colds caused by the other human coronaviruses!”

Whether the cross-reactivity of antibodies on antigens revealed in this study works in the opposite direction is still unknown. Does immunity to the SARS-CoV-2 virus also confer immunity against weaker forms of the coronavirus?

MNT spoke with Dr. David Smith, MAS, FACP, from University of California San Diego Health in La Jolla, who discussed the study’s clinical implications. He stated, “It’s hard to directly interpret these data through a clinical lens. The study does suggest that more related coronavirus immunity helps with SARS-CoV-2 immunity.”

“This gives me hope that COVID-19 vaccines should continue to help protect [against] variants that continue to develop, but, of course, clinical studies will need to assess such speculation and hope.”